Ge-1 is a central component of the mammalian cytoplasmic mRNA processing body

被引:153
作者
Yu, JH
Yang, WH
Gulick, T
Bloch, KD
Bloch, DB
机构
[1] Harvard Univ, Sch Med, Dept Med, Ctr Immunol & Inflammat Dis, Boston, MA 02114 USA
[2] Massachusetts Gen Hosp, Diabet Res Labs, Boston, MA USA
[3] Massachusetts Gen Hosp, Cardiovasc Res Ctr, Gen Med Serv, Boston, MA 02114 USA
关键词
mRNA processing body; mRNA decay; autoantigen;
D O I
10.1261/rna.2142405
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The mRNA processing body (P-body) is a cellular structure that regulates gene expression by degrading cytoplasmic mRNA. The objective of this study was to identify and characterize novel components of the mammalian P-body. Approximately 5% of patients with the autoimmune disease primary biliary cirrhosis have antibodies directed against this structure. Serum from one of these patients was used to identify a cDNA encoding Ge-1, a 1401-amino-acid protein. Ge-1 contains an N-terminal WD40 motif and C-terminal domains characterized by a repeating psi(X2-3) motif. Ge-1 co-localized with previously identified P-body components, including proteins involved in mRNA decapping (DCP1a and DCP2) and the autoantigen GW182. The Ge-1 C-terminal domain was necessary and sufficient to target the protein to P-bodies. Following exposure of cells to oxidative stress, Ge-1-containing P-bodies were found adjacent to TIA-containing stress granules. During the recovery period, TIA returned to the nucleus while Ge-1-containing P-bodies localized to the perinuclear region. siRNA-mediated knock-down of Ge-1 resulted in loss of P-bodies containing Ge-1, DCP1a, and DCP2. In contrast, Ge-1-containing P-bodies persisted despite knock-down of DCP2. Taken together, the results of this study show that Ge-1 is a central component of P-bodies and suggest that Ge-1 may act prior to the 5-decapping step in mRNA degradation.
引用
收藏
页码:1795 / 1802
页数:8
相关论文
共 25 条
[1]   A role for eIF4E and eIF4E-transporter in targeting mRNPs to mammalian processing bodies [J].
Andrei, MA ;
Ingelfinger, D ;
Heintzmann, R ;
Achsel, T ;
Rivera-Pomar, R ;
Lührmann, R .
RNA, 2005, 11 (05) :717-727
[2]   THE IMMUNOREACTIVE REGION IN A NOVEL AUTOANTIGEN CONTAINS A NUCLEAR-LOCALIZATION SEQUENCE [J].
BLOCH, DB ;
RABKINA, D ;
QUERTERMOUS, T ;
BLOCH, KD .
CLINICAL IMMUNOLOGY AND IMMUNOPATHOLOGY, 1994, 72 (03) :380-389
[3]  
Bloch DB, 2005, J RHEUMATOL, V32, P477
[4]   Computational approaches to identify leucine zippers [J].
Bornberg-Bauer, E ;
Rivals, E ;
Vingron, M .
NUCLEIC ACIDS RESEARCH, 1998, 26 (11) :2740-2746
[5]   A Sm-like protein complex that participates in mRNA degradation [J].
Bouveret, E ;
Rigaut, G ;
Shevchenko, A ;
Wilm, M ;
Séraphin, B .
EMBO JOURNAL, 2000, 19 (07) :1661-1671
[6]   Crystal structure of Ski8p, a WD-repeat protein with dual roles in mRNA metabolism and meiotic recombination [J].
Cheng, ZH ;
Liu, YY ;
Wang, CH ;
Parker, R ;
Song, HW .
PROTEIN SCIENCE, 2004, 13 (10) :2673-2684
[7]   Eukaryotic mRNA decapping [J].
Coller, J ;
Parker, R .
ANNUAL REVIEW OF BIOCHEMISTRY, 2004, 73 :861-890
[8]   The DEAD box helicase, Dhh1p, functions in mRNA decapping and interacts with both the decapping and deadenylase complexes [J].
Coller, JM ;
Tucker, M ;
Sheth, U ;
Valencia-Sanchez, MA ;
Parker, R .
RNA, 2001, 7 (12) :1717-1727
[9]   Cytoplasmic foci are sites of mRNA decay in human cells [J].
Cougot, N ;
Babajko, S ;
Séraphin, B .
JOURNAL OF CELL BIOLOGY, 2004, 165 (01) :31-40
[10]   Clinical and serological associations of autoantibodies to GW bodies and a novel cytoplasmic autoantigen GW182 [J].
Eystathioy, T ;
Chan, EKL ;
Takeuchi, K ;
Mahler, M ;
Luft, LM ;
Zochodne, DW ;
Fritzler, MJ .
JOURNAL OF MOLECULAR MEDICINE-JMM, 2003, 81 (12) :811-818